Mutation and expression of the p27(KIP1) and p57(KIP2) genes in human gastric cancer

Jong Yeon Shin, Hyun Seok Kim, Kyung Suk Lee, Jaebong Kim, Jae Bong Park, Moo Ho Won, Seung Wan Chae, Young Hee Choi, Kyung Chan Choi, Young Euy Park, Jae Yong Lee

Research output: Contribution to journalArticlepeer-review

56 Scopus citations


Cyclin-dependent kinase inhibitors (CDKI) are negative regulators of cell cycle progression by binding the cyclin-CDK complex and inhibiting the CDK activity. Genetic alteration in the CDKI genes has been implicated for carcinogenesis. To test the genetic alteration in the p27 and p57 genes, KIP family CDKI genes, 30 gastric tumor-normal pairs and 8 gastric cancer cell lines were analyzed for mutations by polymerase chain reaction-single strand conformational polymorphism (PCR-SSCP). No mutation was detected in these genes although length polymorphisms in the proline-alanine repeat of the p57 gene were detected. When the p27 and p57 mRNAs were analyzed in gastric cancer cell lines by RT-PCR, the p27 mRNA was expressed considerably high in tumor cells but expression of the p57 mRNA was much low in gastric cancer cell lines compared to that of normal cells. The result suggests that inactivation of gene expression rather than mutations in the p57 gene accounts possibly for the involvement of this gene in tumorigenesis of gastric cancer. However, expression of the p27 gene seems to be essential for cell survival.

Original languageEnglish
Pages (from-to)79-83
Number of pages5
JournalExperimental and Molecular Medicine
Issue number2
StatePublished - 30 Jun 2000


  • CDKI
  • Gastric cancer
  • p27
  • p57


Dive into the research topics of 'Mutation and expression of the p27(KIP1) and p57(KIP2) genes in human gastric cancer'. Together they form a unique fingerprint.

Cite this